Renalytix Plc (RENXF)
OTCMKTS · Delayed Price · Currency is USD
0.0400
0.00 (0.00%)
At close: Feb 11, 2026

Renalytix Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
243321134951,077
Market Cap Growth
-44.38%53.30%-83.99%40.56%-91.14%176.19%
Enterprise Value
294026112651,007
Last Close Price
0.040.090.161.011.9615.27
PS Ratio
8.0410.979.3339.4032.12722.27
PB Ratio
-3.44-4.70-2.3819.243.1215.07
P/TBV Ratio
---19.243.1215.07
EV/Sales Ratio
9.6213.4711.3832.9422.04675.32
Debt / Equity Ratio
-1.19-1.19-0.941.740.40-
Asset Turnover
0.460.460.120.080.050.03
Inventory Turnover
7.207.20----
Quick Ratio
0.900.900.521.583.599.31
Current Ratio
1.211.210.581.673.809.46
Return on Equity (ROE)
----242.76%-88.72%-80.88%
Return on Assets (ROA)
-160.99%-160.99%-100.39%-65.43%-51.79%-41.33%
Return on Capital Employed (ROCE)
-1307.70%-1307.70%644.70%-291.50%-139.20%-46.00%
Earnings Yield
-84.61%-62.01%-212.02%-34.02%-47.47%-3.23%
FCF Yield
--54.41%-138.86%-25.42%-48.73%-2.71%
Buyback Yield / Dilution
-182.86%-153.82%-31.59%-11.34%-3.29%-21.00%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.